These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15668002)

  • 21. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli.
    Puerto AS; Fernández JG; del Castillo Jde D; Pino MJ; Angulo GP
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):135-9. PubMed ID: 16406187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-heterocyclic dicarboxylic acids: broad-spectrum inhibitors of metallo-β-lactamases with co-antibacterial effect against antibiotic-resistant bacteria.
    Feng L; Yang KW; Zhou LS; Xiao JM; Yang X; Zhai L; Zhang YL; Crowder MW
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5185-9. PubMed ID: 22796180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
    Queenan AM; Shang W; Flamm R; Bush K
    Antimicrob Agents Chemother; 2010 Jan; 54(1):565-9. PubMed ID: 19884379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
    Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
    Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro antibacterial activity and mechanism of action of J-111,225, a novel 1beta-methylcarbapenem, against transferable IMP-1 metallo-beta-lactamase producers.
    Nagano R; Adachi Y; Hashizume T; Morishima H
    J Antimicrob Chemother; 2000 Mar; 45(3):271-6. PubMed ID: 10702544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-beta-lactamase.
    Toney JH; Hammond GG; Fitzgerald PM; Sharma N; Balkovec JM; Rouen GP; Olson SH; Hammond ML; Greenlee ML; Gao YD
    J Biol Chem; 2001 Aug; 276(34):31913-8. PubMed ID: 11390410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Beta-lactamases and their role in resistance. PART 2: beta-lactamases in 21st century].
    Bedenić B
    Lijec Vjesn; 2005; 127(1-2):12-21. PubMed ID: 16145868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of bla(IMP-22) in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location.
    Pellegrini C; Mercuri PS; Celenza G; Galleni M; Segatore B; Sacchetti E; Volpe R; Amicosante G; Perilli M
    J Antimicrob Chemother; 2009 May; 63(5):901-8. PubMed ID: 19270313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-lactamase inhibitory component from the roots of Fissistigma cavaleriei.
    Yang Z; Niu Y; Le Y; Ma X; Qiao C
    Phytomedicine; 2010 Feb; 17(2):139-41. PubMed ID: 19747808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005).
    Rhomberg PR; Jones RN
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):207-15. PubMed ID: 16949243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-beta-lactamase, IMP-18.
    Hanson ND; Hossain A; Buck L; Moland ES; Thomson KS
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2272-3. PubMed ID: 16723605
    [No Abstract]   [Full Text] [Related]  

  • 33. 4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: first boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity.
    Tan Q; Ogawa AM; Painter RE; Park YW; Young K; DiNinno FP
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2622-4. PubMed ID: 20299220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New leads of metallo-beta-lactamase inhibitors from structure-based pharmacophore design.
    Olsen L; Jost S; Adolph HW; Pettersson I; Hemmingsen L; Jørgensen FS
    Bioorg Med Chem; 2006 Apr; 14(8):2627-35. PubMed ID: 16378729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A specific peptide inhibitor of the class B metallo-beta-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display.
    Sanschagrin F; Levesque RC
    J Antimicrob Chemother; 2005 Feb; 55(2):252-5. PubMed ID: 15659541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
    Mammeri H; Poirel L; Nordmann P
    J Antimicrob Chemother; 2007 Sep; 60(3):490-4. PubMed ID: 17586561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomolar inhibitors of AmpC beta-lactamase.
    Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F
    J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel imidazole substituted 6-methylidene-penems as broad-spectrum beta-lactamase inhibitors.
    Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Yamamura I; Kumagai T; Petersen PJ; Weiss WJ; Lenoy E; Yang Y; Shlaes DM; Ryan JL; Mansour TS
    Bioorg Med Chem; 2004 Nov; 12(22):5807-17. PubMed ID: 15498657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
    Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of disk preparation on detection of metallo-beta-lactamase-producing isolates by the combined disk assay.
    Andrade SS; Picão RC; Campana EH; Nicoletti AG; Pignatari AC; Gales AC
    J Clin Microbiol; 2007 Jun; 45(6):2058-60. PubMed ID: 17409202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.